nelotanserin (RVT-102) / Pfizer, Roivant  >>  Phase 2
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
nelotanserin (RVT-102) / Roivant
NCT00452179: Safety and Efficacy Study of APD125 in Patient With Insomnia

Completed
2
173
US
APD125
Arena Pharmaceuticals
Insomnia
 
06/07
NCT00664664: Subjective Study to Assess the Efficacy of APD125 in Patients With Sleep Maintenance Insomnia

Completed
2
744
US
APD125, Placebo
Arena Pharmaceuticals
Primary Insomnia
10/08
11/08
NCT02640729: Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia

Completed
2
30
US
Nelotanserin, Placebo
Axovant Sciences Ltd.
Lewy Body Dementia, Visual Hallucinations
11/17
11/17
NCT02708186: Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)

Completed
2
34
US
Nelotanserin, Placebo
Axovant Sciences Ltd.
Dementia With Lewy Bodies, REM Sleep Behavior Disorder, Parkinson's Disease Dementia
05/18
05/18
NCT02871427: Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder

Terminated
2
80
US
Nelotanserin
Axovant Sciences Ltd.
Lewy Body Dementia, Dementia With Lewy Bodies, Parkinson's Disease Dementia, Visual Hallucinations, REM Sleep Behavior Disorder
01/19
01/19

Download Options